Algert Global LLC Boosts Stake in Maximus, Inc. (NYSE:MMS)

Algert Global LLC boosted its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 12.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 187,017 shares of the health services provider's stock after buying an additional 20,215 shares during the quarter. Algert Global LLC owned approximately 0.33% of Maximus worth $13,961,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in MMS. Barclays PLC increased its holdings in shares of Maximus by 285.1% in the third quarter. Barclays PLC now owns 170,971 shares of the health services provider's stock valued at $15,927,000 after purchasing an additional 126,573 shares during the last quarter. Virtu Financial LLC acquired a new stake in Maximus during the third quarter worth approximately $319,000. World Investment Advisors LLC boosted its holdings in shares of Maximus by 6.6% during the third quarter. World Investment Advisors LLC now owns 5,289 shares of the health services provider's stock worth $493,000 after acquiring an additional 326 shares during the period. Tidal Investments LLC grew its position in shares of Maximus by 49.1% in the third quarter. Tidal Investments LLC now owns 20,674 shares of the health services provider's stock valued at $1,926,000 after purchasing an additional 6,809 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of Maximus by 8.8% during the third quarter. JPMorgan Chase & Co. now owns 223,766 shares of the health services provider's stock worth $20,846,000 after purchasing an additional 18,143 shares during the period. 97.21% of the stock is currently owned by institutional investors.

Maximus Price Performance

MMS traded up $0.75 during trading on Wednesday, hitting $67.22. 494,672 shares of the stock traded hands, compared to its average volume of 559,507. The business has a 50 day moving average price of $67.69 and a 200 day moving average price of $73.32. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97. The company has a market cap of $3.80 billion, a price-to-earnings ratio of 14.46 and a beta of 0.61.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Equities research analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.79%. Maximus's payout ratio is presently 25.81%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th.

Insider Transactions at Maximus

In other news, Director Jan Madsen sold 2,439 shares of the company's stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares of the company's stock, valued at $1,225,347.87. This represents a 11.88 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the transaction, the insider now directly owns 2,512 shares in the company, valued at $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.60% of the company's stock.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.